GSTA1
Basic information
Region (hg38): 6:52791370-52803860
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn genetic diseases (7 variants)
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GSTA1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 7 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region ? | 1 | 1 | ||||
non coding ? | 0 | |||||
Total | 0 | 0 | 7 | 1 | 1 |
Variants in GSTA1
This is a list of pathogenic ClinVar variants found in the GSTA1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-52791940-T-C | not specified | Uncertain significance (Oct 05, 2023) | ||
6-52792957-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
6-52794144-T-C | not specified | Uncertain significance (Jan 17, 2024) | ||
6-52794148-G-A | not specified | Uncertain significance (May 18, 2023) | ||
6-52794233-C-A | not specified | Uncertain significance (Oct 12, 2022) | ||
6-52794234-A-G | not specified | Uncertain significance (Dec 27, 2023) | ||
6-52794240-G-T | not specified | Uncertain significance (Jan 04, 2024) | ||
6-52794256-A-G | not specified | Uncertain significance (Jun 29, 2023) | ||
6-52796178-G-A | Benign (Jul 17, 2018) | |||
6-52796249-T-C | not specified | Uncertain significance (Nov 30, 2021) | ||
6-52796280-A-C | Likely benign (Apr 06, 2018) | |||
6-52799213-T-C | not specified | Uncertain significance (May 23, 2023) | ||
6-52799231-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
6-52799253-G-A | Benign (Jul 17, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GSTA1 | protein_coding | protein_coding | ENST00000334575 | 6 | 12247 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000173 | 0.257 | 125712 | 0 | 36 | 125748 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.60 | 167 | 118 | 1.41 | 0.00000591 | 1466 |
Missense in Polyphen | 52 | 36.03 | 1.4433 | 511 | ||
Synonymous | -2.39 | 61 | 41.4 | 1.47 | 0.00000205 | 402 |
Loss of Function | 0.119 | 9 | 9.39 | 0.958 | 3.92e-7 | 132 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000119 | 0.000119 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000202 | 0.000202 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000197 | 0.000196 |
Other | 0.000328 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. {ECO:0000269|PubMed:20606271}.;
- Pathway
- Glutathione metabolism - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Fluid shear stress and atherosclerosis - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - other enzymes - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Busulfan Pathway, Pharmacodynamics;Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics;Glutathione metabolism;Nuclear Receptors Meta-Pathway;NRF2 pathway;Estrogen metabolism;Glutathione conjugation;Phase II - Conjugation of compounds;glutathione-mediated detoxification;Biological oxidations;Metabolism;4-hydroxy-2-nonenal detoxification
(Consensus)
Intolerance Scores
- loftool
- 0.890
- rvis_EVS
- -0.18
- rvis_percentile_EVS
- 40.16
Haploinsufficiency Scores
- pHI
- 0.0566
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.426
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.219
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- glutathione metabolic process;epithelial cell differentiation;linoleic acid metabolic process;cellular oxidant detoxification;glutathione derivative biosynthetic process
- Cellular component
- cytosol;extracellular exosome
- Molecular function
- glutathione transferase activity;glutathione peroxidase activity